Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

T2 Biosystems CS (TTOO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 115,675
  • Shares Outstanding, K 44,320
  • Annual Sales, $ 10,500 K
  • Annual Income, $ -51,150 K
  • 60-Month Beta 1.80
  • Price/Sales 11.14
  • Price/Cash Flow N/A
  • Price/Book 10.21

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.30
  • Number of Estimates 3
  • High Estimate -0.28
  • Low Estimate -0.32
  • Prior Year -0.36
  • Growth Rate Est. (year over year) +16.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.45 +5.71%
on 04/22/19
3.28 -21.04%
on 04/11/19
-0.13 (-4.78%)
since 03/25/19
3-Month
2.45 +5.71%
on 04/22/19
5.38 -51.86%
on 02/28/19
-0.94 (-26.63%)
since 01/25/19
52-Week
2.45 +5.71%
on 04/22/19
9.98 -74.05%
on 06/15/18
-4.07 (-61.11%)
since 04/25/18

Most Recent Stories

More News
T2 Biosystems Announces 2019 First Quarter Financial and Operational Results Release and Conference Call Date

T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that it will release its 2019...

TTOO : 2.56 (-1.92%)
New Research Coverage Highlights Franklin Resources, Corporate Office Properties Trust, Guidewire Software, Bemis, T2 Biosystems, and Zosano Pharma -- Consolidated Revenues, Company Growth, and Expectations for 2019

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Franklin Resources, Inc. (NYSE:BEN),...

GWRE : 106.48 (+1.65%)
TTOO : 2.56 (-1.92%)
BMS : 56.79 (-0.51%)
BEN : 35.42 (-0.70%)
ZSAN : 3.91 (-1.26%)
OFC : 27.56 (-0.40%)
Biotech Brief: U.S. Medical Device Market Reaches $156 Billion Mark

Medical technology is an area where the U.S. companies are at the forefront. In fact, according to recent industry publication the: "U.S. remains the largest medical device market in the world, with a...

SGMO : 11.76 (-1.01%)
MLNT : 4.70 (-1.88%)
TTOO : 2.56 (-1.92%)
PFE : 39.36 (-0.03%)
SOLY : 12.00 (-2.68%)
T2 Biosystems and Clinicians to Share Clinical Data in Integrated Symposium and Poster Presentations at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)

T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that the Company will host an...

TTOO : 2.56 (-1.92%)
T2 Biosystems Reports Granting of Inducement Awards

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on March 15,...

TTOO : 2.56 (-1.92%)
T2 Biosystems to Present at the 18th Annual Needham Healthcare Conference

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that John Sprague,...

TTOO : 2.56 (-1.92%)
Watch for T2 Biosystems to Potentially Rebound After Falling 2.66% Yesterday

T2 Biosystems (NASDAQ:TTOO) traded in a range yesterday that spanned from a low of $2.56 to a high of $2.68. Yesterday, the shares fell 2.7%, which took the trading range below the 3-day low of $2.62...

TTOO : 2.56 (-1.92%)
T2 Biosystems Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update

Secured 14 New Instrument Contracts in the Fourth Quarter and 39 total New Instrument Contracts in 2018 that are expected to drive growth in Recurring Test Revenue

TTOO : 2.56 (-1.92%)
Is the Options Market Predicting a Spike in T2 Biosystems (TTOO) Stock?

Investors need to pay close attention to T2 Biosystems (TTOO) stock based on the movements in the options market lately.

TTOO : 2.56 (-1.92%)
After Yesterday's Decline of 12.12%, T2 Biosystems Offers Investors Better Value

T2 Biosystems (NASDAQ:TTOO) traded in a range yesterday that spanned from a low of $3.60 to a high of $4.12. Yesterday, the shares fell 12.1%, which took the trading range below the 3-day low of $4.14...

TTOO : 2.56 (-1.92%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade TTOO with:

Business Summary

T2 Biosystems, Inc. is an in vitro diagnostics company. It has developed a technology platform that is designed to offer a rapid, sensitive and simple alternative to existing diagnostic methodologies. The Company uses its T2 Magnetic Resonance platform, or T2MR, that enables rapid detection of pathogens,...

See More

Key Turning Points

2nd Resistance Point 2.72
1st Resistance Point 2.67
Last Price 2.56
1st Support Level 2.56
2nd Support Level 2.50

See More

52-Week High 9.98
Fibonacci 61.8% 7.10
Fibonacci 50% 6.21
Fibonacci 38.2% 5.33
Last Price 2.56
52-Week Low 2.45

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar